Participant flow

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies · Source last updated 2016-11-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   All patients were administered the following drugs; 1. Fludarabine 30mg/m2 intravenously daily at the same time over 30 min on days -7,-6,-5,-4, and -3 2. Melphalan 140mg/m2 IV on day -2 3. Stem cell infusion on day 0 4. Campath 20mg IV on day -7,-6,-5,-4, and -3

   id

   FG000

   title

   T-cell Depleted Allogeneic Stem Cell Transplantation

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         204

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         204

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice